Hepatic safety profile and glycemic control of pioglitazone in more than 20,000 patients with type 2 diabetes mellitus: Postmarketing surveillance study in Japan
To access this article, please choose from the options below
PII: S0168-8227(06)00399-8
doi:10.1016/j.diabres.2006.08.017
© 2006 Published by Elsevier Inc.
